Hosted on MSN1mon
Sage confirms Biogen’s bid to acquire remaining stake
Biogen currently owns a 10.2% stake in SAGE, and its offer price implies a ~30% premium to the company’s closing price on Friday. More on Biogen, Sage Therapeutics, etc. Biogen Holds On, But ...
Reuters1mon
Biogen Inc
EU regulator reiterates positive recommendation for Eisai-Biogen's Alzheimer's drug The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's ...
Nasdaq13d
Biogen Stock Is Mutating Into a Value Play
Biogen Inc. (NASDAQ: BIIB) has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from those highs to 12-year lows at $137.33. The medical sector biotechnology ...
Nasdaq22d
Biogen's Options Frenzy: What You Need to Know
Investors with a lot of money to spend have taken a bullish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the trades showed up on publicly available ...